Has Kristen Hook received payments from drug or device companies?

Yes. Drug and device makers reported $960 in general payments to Kristen Hook across 45 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kristen Hook did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kristen Hook come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kristen Hook

Pediatric Dermatology · Minneapolis, MNNPI 1053465641

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $835 of the $960 with a category attached, or 87.0%. 19 manufacturers reported payments, led by Pfizer at 33.3% of the total.

$960in general payments, 2019–2025

Across 45 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$320
Regeneron Healthcare Solutions, Inc.$111
Sanofi$99
LEO Pharma Inc.$71
Blueprint Medicines Corporation$60
Incyte Corporation$55
plus $245 from 13 others

$96,102in research payments, 2019–2025

Across 67 payments — averaging $1434.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Amryt Pharma Holdings Ltd$96K

What the payments were for

Speaking & faculty fees$12513%
Food & beverage$83587%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	9	$320
Regeneron Healthcare Solutions, Inc.	7	$111
Sanofi	4	$99
LEO Pharma Inc.	5	$71
Blueprint Medicines Corporation	2	$60
Incyte Corporation	3	$55
Dermavant Sciences, Inc.	2	$33
Sun Pharmaceutical Industries Inc.	1	$32
Dermira, Inc.	2	$29
Boehringer Ingelheim	1	$21
Amgen	1	$18
Bristol Myers Squibb	1	$16
Galderma Laboratories, L.p.	1	$16
Lilly USA, LLC	1	$16
Biofrontera Inc.	1	$15
Springworks Therapeutics, Inc.	1	$14
Verrica Pharmaceuticals Inc.	1	$14
Smith+Nephew	1	$13
Pierre Fabre Pharmaceuticals, Inc.	1	$7

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EUCRISA$125

How this compares

Too few pediatric dermatology providers in Minnesotato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VyjuvekBeremagene Geperpavec-Svdt	48	$1,158,357

Paid to pharmacies, not to this prescriber.

Other pediatric dermatology in Minneapolis

Christina BoullMinneapolis$5K
Ingrid PolcariMinneapolis$1K
Cynthia NicholsonMinneapolis$290
Sheilagh MaguinessMaple Grove$22K
Sarah AschSaint Paul$5K
Jennifer DaySt Louis Park$191

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →